The Race for a Vaccine

Over the weekend, President Trump called off a trip to Pakistan by two of his negotiators for a potential additional round of talks with Tehran, leaving the fate of the cease-fire in limbo. Farnaz Fassihi, who covers Iran for The New York Times, looks at who is in charge of the c ...  Show more

With war, political wrangling and price hikes jockeying for headlines, it’s a rare thing to sit for an hour with a large group of strangers and focus on the small pleasures in life. But that’s what the show “Every Brilliant Thing” is all about. Since 2013, Duncan Macmillan’s audi ...  Show more

On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

Les vaccins contre le Covid-19 sont au centre de toutes les attentions. Ils sont l'espoir auquel se raccrochent les gouvernements du monde entier pour sortir de la crise sanitaire qui nous touche depuis un an. Si leur mise au point s'est faite en un temps record, en matière de ...

Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ...  Show more